Hunter-Fleming Ltd clinical trials
Acquired by Newron Pharmaceuticals SPA, 2008 · source ↗
The registry lists 1 studies whose lead sponsor is Hunter-Fleming Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 21, 2008.
Before and after it joined Newron Pharmaceuticals SPA
- First submitted before Hunter-Fleming Ltd became part of Newron Pharmaceuticals SPA
- 1
- First submitted after Hunter-Fleming Ltd became part of Newron Pharmaceuticals SPA
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Hunter-Fleming Ltd1 study
Something wrong with this grouping? Tell us on the Newron Pharmaceuticals SPA page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Newron Pharmaceuticals SPA studies →
- European Study of HF0220 in Mild to Moderate Alzheimer's Disease PatientsCompletedNCT00357357Phase 2
Sponsor listed in the registry: Hunter-Fleming Ltd · First submitted before Hunter-Fleming Ltd became part of Newron Pharmaceuticals SPA